Navigation Links
Scientists Discover Origin of Malaria
Date:8/3/2009

Discovery Could Lead to Development of New Treatments, Prevent Future Plagues

SAN FRANCISCO, Aug. 3 /PRNewswire-USNewswire/ -- Today scientists reported that they have discovered the origin of malaria, one of the deadliest diseases of humanity. Chimpanzees, native to equatorial Africa, have been identified as the original source of the parasite that likely moved from them to humans via mosquitoes.

An international group of researchers, including senior author Nathan Wolfe, Ph.D., of the Global Viral Forecasting Initiative and Stanford University, made the discovery, published in the Aug. 3 2009 Proceedings of the National Academy of Sciences, by identifying several new parasites from chimpanzees. The newly discovered parasites show that malaria jumped from animals to humans, much the way that HIV, SARS and swine flu originated.

"This discovery shows that ancient diseases, such as malaria, can originate in the same way that modern pandemics do, namely by jumping from animals to humans" Wolfe said. "We now know that malaria, while at least thousands of years old, did not originate in humans but rather was introduced into our species, presumably by the bite of a mosquito that had previously fed on a chimpanzee."

Until now, malaria's origin had been unclear. Although chimpanzees were known to harbor a parasite, called Plasmodium reichenowi, that is closely related to the dominant human malaria parasite, Plasmodium falciparum, most scientists assumed incorrectly that these parasites had co-existed separately in human and chimpanzee ancestors for the last 5 million years.

The newly discovered parasites not only demonstrate how malaria originated, but represent potentially powerful tools for developing vaccines and treatments against this deadly scourge. Discovery of these parasites indicates that there is a much broader range of close relatives to the human parasite than were previously recognized, some of which might provide key insights in drug development or act as vaccines that could prevent human malaria.

"Dr. Wolfe's discovery of the origin of human malaria is a perfect example of the kind of research supported by the NIH Director's Pioneer Award program, which gives outstanding investigators a chance to test exceptionally innovative and potentially paradigm-shifting ideas," said Raynard S. Kington, M.D., Ph.D., acting director of the National Institutes of Health.

Wolfe and his colleagues sampled wild and wild-born captive chimpanzees in Cameroon and Ivory Coast. In Cameroon researchers collected samples from chimpanzees during routine health exams in three different wildlife sanctuaries. They were primarily wild-born animals brought to the sanctuaries after being confiscated by authorities or abandoned by human owners. In Ivory Coast scientists from the Robert Koch Institute and Max Planck Institute for Evolutionary Anthropology collected tissue and blood samples from 10 chimps that had died due to anthrax, respiratory disease or other reasons in the Tai National Park. Samples were analyzed in the laboratory of Stephen Rich, Ph.D., at the University of Massachusetts, Amherst.

"It is now clear that a new disease that successfully jumps from an animal to a human can last not just for decades, but millennia or more," Wolfe said. "This makes the task of stopping future disease spillovers from animals to humans vital, not only for saving lives today, but for the health of people for many generations to come."

Every year malaria:

  • Accounts for 500 million cases per year.
  • Results in more than one million deaths -- mostly children.
  • Includes 1,300 cases in the United States.
  • Cuts economic growth by as much as 1.3 percent in countries with high disease rates.
  • Occurs primarily in tropical and subtropical regions such as Central and South America, Southeast Asia, sub-Saharan Africa, the Caribbean and the South Pacific Islands.

The Global Viral Forecasting Initiative has spent the last ten years developing a global system to prevent pandemics. By coupling innovative surveillance in field sites throughout the world with a consortium of top laboratories, GVFI is able to characterize the diversity of viruses and other agents as they move from animals to humans. GVFI virus hunter Nathan Wolfe, Ph.D., has studied how this happens -- and how frequently it happens -- and has identified a number of new infectious diseases. The group's work provides basic insights into how pandemics are born and employs cutting-edge strategies to prevent the next major pandemic.


'/>"/>
SOURCE Global Viral Forecasting Initiative
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
2. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
3. Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels
4. Scientists Discover Why Teeth Form in a Single Row
5. Scientists Unmask Genetic Markers Associated With Psoriasis
6. 42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases
7. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
8. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
9. Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12
10. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
11. Brain Stem Cells Can Be Awakened, Say Schepens Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 A new ... Disinfectorâ„¢ is the proven ultraviolet-C (UV-C) disinfection solution ... infections (HAIs). Published in the ... Infection Control , the peer-reviewed study of UV-C ... of Vancouver General Hospital and Rochester General Hospital. ...
(Date:3/22/2017)... FinancialBuzz.com News Commentary  ... According to a report by the New Frontier Data, the ... and is projected to grow at a compound annual growth rate ... The medical cannabis market is projected to grow at 12% CAGR ... estimated $13.3 billion in 2025. These projections do not include assumptions ...
(Date:3/22/2017)... , March 22, 2017 TFS is ... and Mr. Ed Tumaian , two global executive positions in ... be joining the Operational Leadership Team and will report to Dr. ... ... comes to TFS with 10 years of medical and scientific expertise ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... Wash Tower Ltd. has ... launch of the Wash Tower, the world's first standalone constant pressure bidet. , The ... the company's website at https://www.washtower.com as well as on its social media ...
(Date:3/22/2017)... ... March 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, ... to accept new patients in need of skilled pediatric dentistry in Rock ... Care offers pediatric patients routine treatments, including cavities, sealants and fluoride applications, in a ...
(Date:3/22/2017)... TX (PRWEB) , ... March 22, 2017 , ... ... medical imaging core lab with extensive therapeutic experience and operational excellence in oncology ... II immuno-oncology clinical trial for the treatment of non-small cell lung cancer and ...
(Date:3/22/2017)... ... 22, 2017 , ... The Tyler Hitchcock Agency, a Dallas ... eastern Texas, is announcing a charity drive in conjunction with the North Texas ... , Consistently a top-rated nonprofit organization for hunger relief, the North Texas ...
(Date:3/22/2017)... ... March 22, 2017 , ... Chris Humphrey Insurance Agency, a North Carolina ... throughout the coastal plains region, is initiating a charity event to raise support for ... first diagnosed with leukemia on a Friday evening in September 2014. At the time, ...
Breaking Medicine News(10 mins):